eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community

  Tools   Community
All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms       Ask question       Write review       Answered/ Unanswered       Reviews       WellConnected

From FDA reports: drug interactions between Sulfatrim And Sulfatrim Pediatric Suspension, Fansidar for a Male patient aged 11

This is a personalized study for a 11 year old male patient. The study is created by eHealthMe based on reports of 20 people who take the same drugs and have drug interactionsfrom FDA.

On Dec, 3, 2014: 20 people who reported to have interactions when taking Sulfatrim And Sulfatrim Pediatric Suspension, Fansidar are studied

Trend of Sulfatrim And Sulfatrim Pediatric Suspension, Fansidar's drug interactions, side effects, and effectiveness reports (3485127)

Information of the patient in this study:

Age: 11

Gender: male

Conditions: Upper Respiratory Tract Infection

Drugs taking:
- Sulfatrim And Sulfatrim Pediatric Suspension
- Fansidar

Drug interactions have: Toxic Epidermal Necrolysis, Stevens-johnson Syndrome

eHealthMe real world results:

Comparison with this patient's adverse outcomes among males aged 11 (±5):

InteractionNumber of reports
Toxic Epidermal Necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)1 (100.00%)
Stevens-johnson Syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)1 (100.00%)

Most common interactions experienced by males aged 11 (±5) in the use of Sulfatrim And Sulfatrim Pediatric Suspension, Fansidar:

InteractionNumber of reports
Stevens-johnson Syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)1
Toxic Epidermal Necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)1

Most common interactions experienced by males aged 11 (±5) in long term use of Sulfatrim And Sulfatrim Pediatric Suspension, Fansidar:

None.

For people in general (regardless of gender or age):

Comparison with this patient's adverse outcomes:

InteractionNumber of reports
Toxic Epidermal Necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)7 (35.00%)
Stevens-johnson Syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)8 (40.00%)

Most common interactions experienced by people in the use of Sulfatrim And Sulfatrim Pediatric Suspension, Fansidar:

InteractionNumber of reports
Uveitis (inflammation of the uvea)10
Stevens-johnson Syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)8
Pleural Effusion (water on the lungs)8
Toxic Epidermal Necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)7
Intra-uterine Death4
Renal Failure Acute (rapid kidney dysfunction)4
Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting)4
Death4
Multi-organ Failure (multisystem organ failure)4
Disseminated Intravascular Coagulation (systemic activation of blood coagulation)4

Most common interactions experienced by people in long term use of Sulfatrim And Sulfatrim Pediatric Suspension, Fansidar:

None.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

About - Terms of service - Privacy policy - Press - Testimonials - Contact us

 
© 2014 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.